Over Half Of Eligible OGIB Patients May Benefit From Given Imaging Ltd.'s Small Bowel Capsule Endoscopy, Technion-Israel Institute of Technology Study
Medical News Today -- Given Imaging Ltd. (NASDAQ: GIVN) announced a new study that shows over half of the eligible patients with occult or obscure gastrointestinal bleeding (OGIB) may benefit from the additional diagnostic information provided by small bowel capsule endoscopy in accordance with existing gastrointestinal (GI) society guidelines, which call for the patient-friendly, non-invasive procedure following a negative upper endoscopy and colonoscopy. Additional studies advocate broader utility of capsule endoscopy in iron deficiency anemia (IDA) and suspected small bowel Crohn's disease. The studies were presented at the Digestive Disease Week(R) (DDW) 2009 conference taking place in Chicago from May 30 - June 4, where Given Imaging also demonstrated a new, simplified procedure for performing PillCam(R) capsule endoscopy of the small bowel and the latest version of its RAPID(R) Software Suite at booth #2235 at the conference.